STSophie G. Tillotson

Sophie G. Tillotson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophie G. Tillotson has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Skin in the Game: Antibiotic Stewardship Within Dermatology

    by Sophie G. Tillotson, Jamie B. Harris, Lauren B. Solberg

    Johnson et al. (2026) make compelling ethical arguments for limiting antibiotic use to the shortest effective duration, but chronic dermatologic conditions introduce additional considerations that ...

  • Open Access

    Addressing Common Oral Contraceptive Pill Concerns for the Primary Care Provider

    by Amelia C. Inclan, Danielle Snyder, Sophie G. Tillotson, Katelyn E. Flaherty, Angelica Byrd, Alyssa Pasvantis, Charlotte Chaiklin

    Primary care providers are increasingly tasked with providing basic gynecologic care, including contraceptive therapy, to their patients. In the United States, oral contraceptive pills are the most frequently prescribed form of contraception; thus, it is critical that primary care providers are well versed in addressing common patient questions. Well-documented concerns relating to oral contraception initiation include changes in weight, mood, cancer risk, libido, acne, and infertility. Herein, we provide a clinical case example of a patient with these common concerns, review the related evidence, and suggest appropriate counseling with the goal of helping primary care clinicians provide the highest level of evidence-based oral contraceptive care.

  • Utilizing Artificial Intelligence: Machine Learning Algorithms to Develop a Preoperative Endometriosis Prediction Model

    by Danielle L. Snyder, Silvana Sidhom, Corinne E. Chatham, Sophie G. Tillotson, Ruben D. Zapata, François Modave, Miranda Solly, Amira Quevedo, Nash S. Moawad


  • Recent advances in laser interstitial thermal therapy in the treatment of brain metastases and radiation necrosis

    by Siddharth Shah, Amelia H. Alberts, Sophie Tillotson, Hritvik Jain, Brandon Lucke-Wold

    Purpose This manuscript reviews advancements in Laser Interstitial Thermal Therapy (LITT) for treating brain metastases and radiation necrosis, emphasizing its minimally invasive nature and precision in targeting deep-seated or eloquent area lesions. It analyzes studies from 2011 to 2024 to evaluate LITT’s efficacy, safety, and complications while highlighting the need for standardized clinical endpoints. Despite its potential, LITT remains a secondary treatment due to limited high-level evidence, requiring further research and multidisciplinary collaboration. Methods A systematic PubMed search identified 2,004 articles on LITT for brain metastases and radiation necrosis. Filtering for studies from 2011 to 2024 resulted in 60 selected articles: 4 clinical trials, 22 observational studies, 3 case reports, 2 case series, and the rest review articles. Relevant data were extracted, analyzed, and compiled for this review. Results LITT is primarily used for lesions unsuitable for open craniotomy, such as deep-seated or eloquent-area tumors. Literature supports its increasing neuro-oncological applications, particularly in brain metastases, gliomas, meningiomas, and radiation necrosis. Conclusion The evolving landscape of brain metastasis treatment underscores the importance of a multidisciplinary approach incorporating standardized reporting, advanced imaging, and molecular diagnostics. Further innovation and collaboration are needed to optimize LITT’s role in neuro-oncology and address treatment challenges in the era of personalized medicine.


  • Open Access

    Young and naïve B cells are a diagnostic pitfall in pediatric tonsillectomies

    by Sophie Tillotson, Ping Shi, Elizabeth Ray, Robert P Seifert

    Tonsillar marginal zone hyperplasia may mimic mucosa-associated lymphoid tissue lymphoma, a rare diagnosis in children. Histologically, both entities can demonstrate expansion of the marginal zone with disruption of follicular architecture. However, marginal zone hyperplasia may appear polyclonal by flow cytometry. We present two pediatric tonsillectomy cases with tonsillar marginal zone hyperplasia and discuss the diagnostic challenges this poses in the pediatric population. Both tonsillectomies demonstrated expansion of marginal zones with partial architectural effacement, and flow cytometric analysis of both cases detected lambda light chain restricted, CD20(bright) B cells without CD38. Authors have suggested that the lambda restricted B cells in this setting represent naïve, unmutated B cells with preferential, but polyclonal, lambda expression. Our cases are in line with this thought. While robust, BIOMED-2 primer PCR can show dominant IgK peaks, which may be misinterpreted. This presents a diagnostic pitfall in the workup of pediatric tonsils that community pathologists must consider.